Actively Recruiting
Randomized, Double-Blind Study of Yufeng Ningxin Tablets Versus Placebo for Adults With Hypertension
Led by Beijing Anzhen Hospital · Updated on 2026-09-30
350
Participants Needed
16
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of Yufeng Ningxin, a traditional Chinese medicine, on patients with hypertension. Although previous animal studies and small clinical trials have suggested that Yufeng Ningxin may lower blood pressure, this phase 4 double-blind, randomized controlled trial aims to rigorously assess its efficacy and safety in a larger patient group. The trial is sponsored by Beijing Anzhen Hospital and focuses on adults aged 18 to 65 with newly diagnosed or treated hypertension. Participants are randomly assigned to one of two groups one group receives Yufeng Ningxin tablets, and the other receives a matching placebo. Both treatments are taken as five tablets per dose, three times daily for eight weeks. The study uses a quadruple masking design to ensure unbiased results. The primary treatment period lasts eight weeks, during which participants take the study medication as directed. During the trial, participants will undergo regular blood pressure measurements and assessments of other health markers related to hypertension, including ambulatory blood pressure monitoring and blood tests for cholesterol and glucose levels. Researchers will also analyze changes in gut microbiota and headache impact scores. Safety is monitored through tracking adverse events, hospitalizations, and emergency visits throughout the eight weeks. Participants will be closely followed to measure the change in systolic blood pressure from the start to the end of treatment.
CONDITIONS
Brief Title
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
Research Team
R
Ruixue Yang, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here